Trial · NCT01907100

Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo_Phase II	43
Overall Study	STARTED	Nintedanib_Phase II	44
Overall Study	STARTED	Placebo_Phase III	229
Overall Study	STARTED	Nintedanib_Phase III	229
Overall Study	Treated Patients	Placebo_Phase II	41
Overall Study	Treated Patients	Nintedanib_Phase II	44
Overall Study	Treated Patients	Placebo_Phase III	228
Overall Study	Treated Patients	Nintedanib_Phase III	227
Overall Study	COMPLETED	Placebo_Phase II	1
Overall Study	COMPLETED	Nintedanib_Phase II	4
Overall Study	COMPLETED	Placebo_Phase III	82
Overall Study	COMPLETED	Nintedanib_Phase III	83
Overall Study	NOT COMPLETED	Placebo_Phase II	42
Overall Study	NOT COMPLETED	Nintedanib_Phase II	40
Overall Study	NOT COMPLETED	Placebo_Phase III	147
Overall Study	NOT COMPLETED	Nintedanib_Phase III	146

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01907100/flow